Stephens Inc’s Transmedics TMDX Stock Holding History

Stephens Inc’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-142,350	Closed	-$5.91M	–	1377
2021 Q1	$5.91M	Buy	+142,350	New	+$4.38M	0.1%	218

Other funds holding TMDX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SCP

Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KXA

KPCB XIII Associates Menlo Park, California $186M AUM 11.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stephens Inc's TMDX Position: Q2 2021 in Review

Stephens Inc sold out of Transmedics (TMDX) in Q2 2021, closing a stake of 142,350 shares — an estimated $5.91M sold.

Stephens Inc first reported a position in TMDX in Q1 2021 and held it in 1 quarter. The position peaked at $5.91M in Q1 2021. 123 funds tracked by Wall St. Rank hold TMDX as of Q2 2021.

Stephens Inc reported no remaining Transmedics position as of Q2 2021 after selling out during the quarter.
Stephens Inc sold 142,350 Transmedics shares in Q2 2021, an estimated $5.91M.
Stephens Inc first reported a position in Transmedics in Q1 2021 and held it in 1 quarter.
Stephens Inc's Transmedics position peaked at $5.91M in Q1 2021.
123 funds tracked by Wall St. Rank held Transmedics as of Q2 2021.

Based on Stephens Inc's 13F filing for Q2 2021, filed 12 Aug 2021.